The prevalence of vitamin B12 deficiency in the population appears to be increasing. Originally vitamin B12 deficiency was quite a rare condition, mainly associated with anaemia caused by antibodies to intrinsic factor or parietal cells (pernicious anaemia),. The condition is now much more common and can be the result of a wide range on conditions such as those caused by malabsorption due to atrophic gastritis, the use of PPIs, GORD medication, certain drugs, low dietary intake such as occurs in veganism and vegetarianism, intestinal parasites such as Giardia lmblia, Blastocystis hominilis, fish tapeworms, Ascaris lumbricoides, Entomoeba histolytica, roundworms, hookworms, certain religions, such as 7th Day Adventists, Rastafarians, and excessive smoking. More recently vitamin B12 deficiency has been shown to also occur as a result in functional vitamin B2 deficiency as occurs in hypothyroidism and lack of dietary intake of vitamin B2, Iodine, Selenium and/or Molybdenum. As such the condition has become much more common and conservatively may affect up to 20% of the population.
Vitamin B12 deficiency is arguably the most under-diagnosed condition in the community. "In general, doctors are trained to recognize only the blood abnormalities associated with B12 deficiency - macrocytosis. B12 deficiency, however, mimics many other diseases and often physicians fail to confirm B12 deficiency and therefore fail to test for it. The development of vitamin B12 deficiency is a slow and insidious process, which may take several years to manifest itself. During this time there can be progressive loss of vitamin B12 in the cerebrospinal fluid (CSF), which precedes overt deficiency as measured in serum, and without anaemia or macrocytosis.
Vitamin B12 deficiency has been associated with the use of the following drugs: Prilose, Yosprala, Prevacid, Dexilent, Aciphex, Protonix, Nexium, Vimovo, Zegerid, cholestyramine, cymetidine, clofibrate, colchicine, Isotretinoin (Accutane), methotrexate, methyldopa, neomycin, omeprazole, some oral contraceptives, phenobarbital, ranitidine, tetracyclines, valproic acid, anti-epileptic drugs (carbamazipine and others) and zidovudine (AZT).
It has been known for over 40 years that the use of nitrous oxide in anaesthesia (laughing gas) or in recreational abuse, can cause vitamin B12 deficiency (Shah and Murphy, 2019: Tani etal, 2019; Oussalah etal, 2019; Chi, 2018; Stockton etal, 2017; Massey etal, 2016: Garakani etal, 2014; Safari etal, 2013; Chiang etal, 2013; Krajewski etal, 2007; Cohen etal, 2007; Jameson etal, 1999; Smith, 2001: Deleu etal, 2001; Mayall, 1999; Horne and Holloway, 1997: Kinsella and Green 1995; Carmel etal, 1993; Koblin etal,1990; O'Leary etal, 1985; van der Westhuyzen and Metz, 1984; 1982; Lumb etal, 1982; Kondo etal, 1981: Seteinberg etal, 1981; McKenna etal, 1980; Linnell etal, 1978; Deacon etal, 1978). Post surgical complications of the use of Nitrous include peripheral neuropathy (Neuveu etal, 2019: Egan, 2018: Kaski etal, 2017; Richardson 2010), metabolic encephalopathy (Vive etal, 2019), myeloneuropathy (Edigin etal, 2019; Friedlander and Davies, 2018; Alt etal, 2011; Waklawik etal, 2003; Sesso etal, 1999: Nestor and Stark, 1996), neuropathy (Gullestrup etal, 2019; Conaerts etal, 2017:Middleton and Roffers, 2018), pancytopenia (Norris and Mallia, 2019), Myopathy (Williamson etal, 2019), myelopathy (Dong etal, 2019; Mancke etal, 2016; Probasco etal, 2011: Hathout and El-Saden, 2011; Pema et al, 1998), severe neuropsychiatric symptoms (Lundin etal, 2019), combined degeneration of the spinal chord (Lan etal, 2019; Patel etal, 2018; Anderson etal, 2018; Antonucci, 2018; Keddie etal, 2018; El-sadawi etal, 2018; Yuan etal 2017: Buizert etal, 2017; Chen and Huang, 2016; Pugliese etal, 2015: Chaugny etal, 2014; Cheng etal, 2013; Lin etal, 2011; Wijesekera, etal, 2009; Renaud etal, 2009: Wu etal, 2007; Ahn and Brown, 2005 Ilniczky etal, 2003: Beltramello etal, 1998: Rosener and DIchgans, 1996), neurotoxicity (Johnsonn etal, 2018), neuronopathy (Morris etal, 2015), polyneuropathy (Alarcia etal, 1999), psychosis (Sethi etal, 2006), dementia (El Otmani etal, 2007), ataxia (Miller etal, 2004), megaloblastic anemia (Barbosa etal, 2000), neurological impairment (McNeeely etal, 2000), neurologic decompensation (Felmet etal, 2000), neurologic degeneration (Flippo and Holder, 1993), spastic paraparesis (Lee etal, 1999).
Deficiency of vitamin B12 in the cerebro-spinal fluid can lead to brain atrophy (shrinkage), rolex replica subacute combined degeneration of the spinal cord, cerebrovasular disease, dementia, Alzheimer's disease and has been postulated as being causative for Parkinson's disease, and multiple sclerosis.
Vitamin B12 deficiency in the elderly has been associated with a slow and unstable gait, numbness and tingling in the hands and feet, urinary and fetal incontinence, hearing loss and an increased incidence of bone fracture.
Vitamin B12 deficiency in pregnant mothers is associated with an increased incidence of neural tube defects in the young and the development of Autism in the new born.
Apart from the conditions mentioned above deficiency in either vitamin B12 or folate often leads to hyperhomocystinaemia, Audemars Piguet Replica Watches which has been associated with MS, AD, dementia, cardiovascular disease, an increased risk of thrombosis, reduced glomerular filtration rate, stroke, ischemic heart disease, mental retardation and seizures, ectopia lentis, secondary glaucoma, optic atrophy, retinal detachment, skeletal abnormalities, osteoporosis, neurological dysfunction, epilepsy, psychiatric symptoms, dementia, Parkinson's disease, neoplasia, cognitive impairment, autism, cretinism, allergy, depression, fatigue, low CoQ10, low creatine, and many other conditions.
Once a person is deficient in vitamin B12, it is almost impossible to overcome this deficient through dietary supplementation, particularly if the underlying cause is not removed/cured. Thus persons who are deficient normally require regular injections of vitamin B12, Recently it has been found that it is possible to obtain vitamin B12 through application to the skin using specialized topical technology described in this site. Vitamin B12 deficiency can be further exacerbated in the presence of MTHFR genetic mutations.
Vitamin B12 deficiency (<250 ρmol/L) is associated with cognitive impairment. Low vitamin B12 levels have also been associated with multiple sclerosis,.
Pregnant women with vitamin B12 levels below 250 pmol/L have twice the incidence of children with neural tube defects than those with higher levels.
Post menopausal women with low levels of vitamin B12 have been shown to have a higher risk of breast cancer (see http://lpi.oregonstate.edu/infocenter/vitamins/vitaminB12/ )
Vitamin B12 deficiency results in lower production of the methylating agent S-Adenosylmethionine and has been associated with hypomethylation of DNA (James etal, 2002, 2008; Yi etal, 2000), which may be the instigating factor in a higher levels of breast cancer seen in post menopausal women (see above).
Vitamin B12 deficiency can occur after bowel resection, or gastric by-pass surgery. Vitamin B12 deficiency can occur due to atrophic gastritis, a condition that effects 10-30% of the elderly. Other causes of vitamin B12 deficiency include achlorhydria, ageing, use of PPIs, use of Nitrous Oxide anaesthetics, excessive antibiotics or anti-convulsants (often used in persons with epilepsy), gastrectomy, especially of the cardiac or fundus, liver disease or cancer, megadoses of vitamin C and/or copper, pregnancy, intestinal parasites such as Giardia, fish tapeworms, anorexia nervosa, certain religions, such as 7th Day Adventists, Rastafarians, and excessive smoking. Vitamin B12 deficiency can be a serious complication of Metformin use in people with diabetes. Recently it has been shown that vitamin B12 deficiency can be a serious complication of cancer chemotherapy using methotrexate following treatment of psoriasis and rheumatoid arthritis.
Hypothyroidism is often also associated with vitamin B12 deficiency Individuals with hypothyroidism have a reduced capacity to convert riboflavin (vitamin B2) to flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD). This then results in the reduced capacity to recycle folate leading to "sacrificial" use of methyl cobalamin for the methylation cycle, ultimately leading to vitamin B12 deficiency (see the section on VB12 and MTHFR and VB12 and MTRR).
Dietary insufficiency of folate can reduce the ability to regenerate methyl B12, thereby causing vitamin B12 deficiency. Dietary insufficiency of iodine, selenium and/or molybdenum can lead to functional vitamin B2 deficiency, due to their role in converting dietary vitamin B2 (riboflavin), into the two active forms of the vitamin, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). The result is very similar to the effect of hypothyroidism, and supplementation with one or all of these metals is required to overcome the deficiency, even in the presence of adequate vitamin B2 (riboflavin) intake.
Mutations in the genes for several enzymes involved in the folate cycle and methylation can also lead to vitamin B12 deficiency (vzi MTHFR, MTR, MTRR, amongst others) and also in inherited genes involved in the proteins involved in vitamin B12 processing within the cell (cblA, B, C, D, E, F).
In the USA and Australia, normal levels of vitamin B12 have been determined to be in the range 180-750 pmol/L (244-1017 pg/ml), with vegans normally much lower at around 110 pmol/L, being regarded as deficient. The definition of deficiency is very random and appears to vary from country to country. Recently, many studies looking at biological markers of vitamin B12 deficiency (MMA and Hcy) as well as neurological markers of deficiency, have suggested that deficiency may start at 300 pmol/L or higher (406 pg/ml)(Ulak etal, 2016), which is also regarded as the lower level of the normal range by the Japanese health authority. In South Korea, vitamin B12 deficiency is defined as vitamin B12 <300 pg/ml. It is estimated that as many as two thirds of the people who are in the lower range of serum vitamin B12 levels (190-300 pmol/L) may have functional vitamin B12 deficiency, thus the true level of vitamin B12 deficiency may be as high as 14-40%, depending upon the population.
Subclinical deficiency in vitamin B12 (<250 pmol/L) can be monitored by rises in the level of homocysteine (Hcy) (>10 umol/L) and methylmalonic acid (>200 nmoll/L). Increased levels of Hcy is associated with vascular inflammatory disease and increases in cardiovascular disease, as well as reduction in eGFR (Ahmed etal, 2019), whilst increases in MMA can result in destruction of the myelin sheath around neurones.
One of the problems with the measurement of vitamin B12 in serum is that current methods do not determine which analogue(s) is(are) present. Thus, if a subject has been injected with cyanocobalamin and then serum vitamin B12 is measured, the subsequent measurement, which shows increased vitamin B12 really only establishes that the injection has been successful. It does not "tell" you if the cyanocobalamin (CN-B12) has been converted to methyl or adenosyl B12.
More recently a new test, called the Active B12 test, has been added to the list of tests, pertaining to measure levels of vitamin B12 in serum. This test is poorly named, as the test measures a structural change in the shape of one of the vitamin B12 binding proteins in serum, transcobalamin, when it binds to some form of vitamin B12 (of unknown identity) as such it does not at all tell you if the vitamin B12 that is bound is biologically active or totally destroyed and inactive. This "finer" point of the assay has been missed by all but a few, and is reflected in the many papers that have shown that the measurement of Holo-TC was not predictive of B12 status as defined by macrocytosis (Wickramasinghe and Ratnayaka, 1996; England and Linell, 1980), however this information is not stressed bythose purveying the test. Once again it does not determine if in fact the subject has the active forms of vitamin B12 (adenosyl and methyl B12), and as such has very questionable utility. Unfortunately this aspect of the test is not stated on the general Information Sheets for the test.
Measurement of serum vitamin B12 can lead to paradoxical results, thus a person may have many symptoms of vitamin B12 deficiency, but measurement of serum vitamin B12 does not show deficiency, a condition called "Paradoxical B12 Deficiency". Thus, whilst the serum may have elevated levels of vitamin B12, the vitamin B12 is an inactive analogue such as Co(II)B12, or more likely cyanocobalamin or hydroxycobalamin. Determination of active vitamin B12 is therefore better achieved through the measurement of MMA, Homocysteine, or elevations in Homovanillic acid, Vanillylmandelic acid, Quinolinic Acid, Kynurenic Acid, or 5-Hydroxyindoleacetic acid. Such determinations are readily obtained using a simple urinary Organic Acids Test.
Paradoxical vitamin B12 deficiency is arguably the most common form of vitamin B12 deficiency, its origin is very poorly understood and poses many problems for patients and clinicians, and often leads to rather erroneous conclusions regarding the utility, or not, of supplementing with vitamin B12. It should though be an "alert" warning for both as it indicates that the measured, or injected or orally administered vitamin B12 is not being properly processed to the two active forms Adenosylcobalamin or Methylcobalamin, thereby suggesting that potentially a functional B2 deficiency should be addressed prior to treatment. Numerous examples of publications where paradoxical vitamin B12 deficiency have been observed occur (Ahmed etal, 2019; Andres etal, 2013; Chiche etal, 2008; Arendt and Nexo, 2012; Deneuville etal, 2009; Corbetta eta; 2015), and have been associated with a wide range of conditions including hypothyroidism, Lyme disease, Chronic Fatigue Syndrome, functional B2 deficiency, anorexia nervosa, autism, solid neoplasms, myeloproliferative blood disorders and liver diseases.
Vitamin B12 deficiency can result in the following conditions
Ataxia (poor muscle do-ordination),
Disorientation, psychoses, schizophrenia, ADHD
Fatigue, being easily tired
Glossitis, impaired lymphocyte response,
Memory loss, dementia, cognitive decline, brain fog, fuzzy thinking
Decreased libido, low sperm count, erectile dysfunction, low testosterone,
increased rate of miscarriage in women, ,
Paresthesia (tingling of fingers, toes, arms, legs, etc),
Restless leg syndrome
Progressive peripheral neuropathy with pronounced anemia,
Brain atrophy, and macrocytic cells.
Increased incidence of canker sores.
Vascular dementia, and
Insomnia, or trouble sleeping through the night
Food intolerance, particularly to histamines
Incontinence of bowel or bladder, including "having to get up during the night".
Irregular or poor control of blood pressure, and irregular breathing patterns
Inability to lose weight.
Mental delay in children
Chronic Fatigue Syndrome
Lack of motivation
Mood swings, temper tantrums
Ocular neuropathic pain (1)
The methods used for measurement of vitamin B12 levels in serum do not determine what form of vitamin B12 is present in the serum, nor what the vitamin B12 is bound to. Thus, in individuals supplementing with high doses of vitamin B12, the subsequent measurement of vitamin B12 is generally a reflection of the analogue of vitamin B12 used in the supplements. Thus, if cyanocobalamin (the inactive vitamer) has been used in supplementation, this is the form measured, Similarly for hydroxycobalamin Similarly the generally used detection methods do not distinguish if the vitamin B12 (of whatever form) is free, or bound to transcobalamin II (the form required for uptake into the cell) or to haptocorrin (the form that is unavailable to the cell). Care must therefore be taken in assuming that just because vitamin B12 levels have been increased or are high in serum the vitamin B12 may either not be bound to transcobalamin II, or it is not the active forms, adenosyl or methylcobalamin.
Vitamin B12 has been used in therapy for many conditions including AIDS/HIV support, anaemia, anaemia of pregnancy, pernicious anaemia, asthma, atherosclerosis, allergies, atopic dermatitis, contact dermatitis, psoriasis, seborrheic dermatitis, bursitis, sciatica, canker sores, chronic fatigue syndrome, Alzheimer?s disease, dementia, depression, Crohn?s disease, diabetes mellitus, diabetic neuropathies, neuralgias, post-herpetic neuralgia, diabetic retinopathy, fatigue, herpes zoster, high cholesterol, high blood homocysteine levels, insomnia, male infertility, tinnitus, viral hepatitis, and vitiligo. Recent studies have shown that high dose vitamin B12 treatment can slow or prevent brain shrinkage and loss of cognitive impairment. High dose formulations have also been shown to reverse bowel and bladder incontinence.
Vitamin B12 insufficiency can be prevented either by adherence to a diet that is sufficient in vitamin B12 (see link), by the use of supplements, by injection of vitamin B12 or via topical administration of vitamin B12. Persons who are deficient due to poor absorption, or through conditions affecting absorption require regular vitamin B12 supplementation either via vitamin B12 injections or by regular application of topical vitamin B12. In addition, due to the absolute requirement for the two active forms of vitamin B2, FMN and FAD, persons need to ensure that they receive adequate levels of vitamin B2, Iodine (150-300 ug/day), selenium (55-200 ug/day) and Molybdenum (100-300 ug/day) (See hypothyroidism, mthfr, mtrr )
Unfortunately it is almost impossible to to overcome deficiency once it occurs, through either a change in diet or by the use of standard supplements. The normal uptake system in the gut for vitamin B12 is not sufficient to deliver enough vitamin B12 to overcome deficiency, a situation made even worse in those who have compromised intestinal uptake, are on various drugs or take metformin. Prompt treatment of B12 deficient patients is required to prevent progressive, irreversible neurological and cognitive impairment. In addition, measurement of serum vitamin B12 levels may not be indicative of deficiency in the central nervous system (CNS), particularly during periods of vitamin B12 supplementation, where it may be possible to significantly boost serum levels of vitamin B12, however, levels in the CNS may be relatively unchanged, or only slightly increased.
The use of vitamin B12 in supplements for treatment of deficiency is controversial with many studies showing no benefit being obtained from standard supplements as the amount of vitamin B12 in the standard supplements is too low, and because almost invariably the supplement contains cyanocobalamin (a synthetic pro-vitamin) rather than adenosylcobalamin or methylcobalamin, the two natural forms of the vitamin. Furthermore, studies with high dose oral supplements with cyanocobalamin were not effective in restoring normal levels of homocysteine or methylmalonic acid, in reversing clinical signs of deficiency, or in maintaining normal levels of serum vitamin B12 once supplements were ceased. In addition, high dose oral supplements have NOT been shown to be able to increase the concentration of vitamin B12 in the cerebral spinal fluid, or the brain, nor to improve mini mental score estimations in dementia. Furthermore, in inflammatory conditions where there are high circulating levels of homocysteine, vitamin B12 introduced by supplements is quickly inactivated to form Co(II)-cobalamin (Co(II)B12), which must be activated by the B2-dependent enzyme MTRR before it can be effective..
The main powerhouses for energy production within the cell are the mitochondria. Within the mitochondria, fatty acids, sugars and amino acids can be converted to energy in the form of ATP via the glycolysis, Krebs cycle and the Electron Transport Chain. . Whilst is it is generally accepted that the B group vitamins play an essential role in energy production, vitamin B12 has several unique roles to play. Through its interaction with the folate and methylation cycles, methylcobalamin contributes the methyl group that is essential for the production of creatine (2-(Methylguanidino)ethanoic acid). In the muscles creatine and creatine phosphate supply "instant" energy through the conversion of creatine phosphate to ATP. Carnitine, formed from the break-down of N-methyl-lysine is essential for transport of free fatty acids into the mitochondria for use in energy production. In addition, methylcobalamin, through its role in the production of S-AdenosylMethionine (SAM), also is essential for the production of the electron-shuffle molecule ubiquinone (CoQ10), and in methyl B12 deficiency CoQ10 levels decrease. Elevated levels of SAM are also required in order to turn on the enzyme cystathionine beta synthase, and to pull the sulphur, originally resident in methionine, through CBS to generate iron-sulphur complexes, and in reduced B12 levels the activity of Fe-S proteins can be observed to decrease. The activity of one of these, aconitase, is critical for energy movement around Krebs cycle and in reduced B12, aconitase activity is reduces. Reduced aconitase activity has been associated with reduced mini mental score estimations, and dementia. In the mitochondria, adenosylcobalamin serves as an essential co-factor in the enzyme methylmalonyl-Co mutase, which utilizes odd chain fatty acids and odd chain amino acids for energy production. A deficiency of adenosylcobalamin can in itself lead to alterations in mitochondrial morphology and function.
Deficiency in adenosylcobalamin leads to the accumulation of methylmalonic acid, which disrupts normal glucose and glutamic acid metabolism in the cell due to its inhibitory activity on the Krebs cycle and by inhibition of ATP synthase. Continued deficiency of adenosylcobalamin, with resultant reduction in energy output can lead to anorexia, lacrimation, alopecia, and eventual emaciation. In addition there is a build up of lesions in the liver and the development of optic neuropathies.
Elevated MMA also results in the formation of faulty lipids for incorporation into the myelin sheath of nerves.
Several studies have also shown that mitochondrial function can be affected by the generation of reactive oxygen species (ROS), which can result from decreased levels of glutathione within the cells due to VB12 deficiency and also because vitamin B12 is known to be a scavenger of nitric oxide.
In addition vitamin B12 deficiency has a dramatic effect on energy levels within the cell due to
decreased production of creatine and hence lower levels of creatine phosphate,
reduced production of CoQ10, and hence lower transfer of energy along the electron transport chain,
reduced fatty acid uptake into the mitochondria due to lower production of carnitine,
reduced metabolism of odd chain fatty acids, and branched chain amino acids.
Further Information on the role of vitamin B12 in energy production and mitochondria
Nitrous Oxide and Vitamin B12 deficiency
Vive MGD, Anguelova GV, Duim S, Hofstee HMA. Metabolic encephalopathy caused by nitrous oxide ('laughing gas') induced hyperammonaemia. BMJ Case Rep. 2019 Nov 25;12(11). pii: e232163. doi: 10.1136/bcr-2019-232163. PubMed PMID: 31772134.
Neveu J, Perelman S, Suisse G, Monpoux F. Severe hyperhomocysteinemia and peripheral neuropathy as side effects of nitrous oxide in two patients with
sickle cell disease. Arch Pediatr. 2019 Oct;26(7):419-421. doi: 10.1016/j.arcped.2019.09.006. Epub 2019 Oct 17. PubMed PMID: 31630905.
Edigin E, Ajiboye O, Nathani A. Nitrous Oxide-induced B12 Deficiency Presenting With Myeloneuropathy. Cureus. 2019 Aug 6;11(8):e5331. doi:10.7759/cureus.5331. PubMed PMID: 31598438; PubMed Central PMCID: PMC6777927.
Tani J, Weng HY, Chen HJ, Chang TS, Sung JY, Lin CS. Elucidating Unique Axonal Dysfunction Between Nitrous Oxide Abuse and Vitamin B12 Deficiency. Front Neurol. 2019 Jul 9;10:704. doi: 10.3389/fneur.2019.00704. eCollection 2019. PubMed PMID: 31354607; PubMed Central PMCID: PMC6633399.
Nouri A, Patel K, Montejo J, Nasser R, Gimbel DA, Sciubba DM, Cheng JS. The Role of Vitamin B(12) in the Management and Optimization of Treatment in Patients With Degenerative Cervical Myelopathy. Global Spine J. 2019 May;9(3):331-337. doi: 10.1177/2192568218758633. Epub 2018 May 17. Review. PubMed PMID: 31192102; PubMed Central PMCID: PMC6542160.
Gullestrup A, Jensen RB, B?gevig S, Nilsson PM. [Acute neuropathy and liver injury following the abuse of nitrous oxide]. Ugeskr Laeger. 2019 May 13;181(20).
pii: V12180890. Danish. PubMed PMID: 31124452.
Norris F, Mallia P. Lesson of the month 2: A case of nitrous oxide-induced pancytopenia. Clin Med (Lond). 2019 Mar;19(2):129-130. doi: 10.7861/clinmedicine.19-2-129. PubMed PMID: 30872294; PubMed Central PMCID:
Williamson J, Huda S, Damodaran D. Nitrous oxide myelopathy with functional vitamin B (12) deficiency. BMJ Case Rep. 2019 Feb 13;12(2). pii: e227439. doi:
10.1136/bcr-2018-227439. PubMed PMID: 30765444.
Lundin MS, Cherian J, Andrew MN, Tikaria R. One month of nitrous oxide abuse causing acute vitamin B (12) deficiency with severe neuropsychiatric symptoms.
BMJ Case Rep. 2019 Feb 7;12(2). pii: bcr-2018-228001. doi: 10.1136/bcr-2018-228001. PubMed PMID: 30737329.
Lan SY, Kuo CY, Chou CC, Kong SS, Hung PC, Tsai HY, Chen YC, Lin JJ, Chou IJ, Lin KL; PCHAN Study Group. Recreational nitrous oxide abuse related subacute combined degeneration of the spinal cord in adolescents - A case series and literature review. Brain Dev. 2019 May;41(5):428-435. doi: 10.1016/j.braindev.2018.12.003. Epub 2019 Jan 2. Review. PubMed PMID: 30611595.
Dong X, Ba F, Wang R, Zheng D. Imaging appearance of myelopathy secondary to nitrous oxide abuse: a case report and review of the literature. Int J Neurosci.
2019 Mar;129(3):225-229. doi: 10.1080/00207454.2018.1526801. Epub 2018 Dec 4.Review. PubMed PMID: 30234413.
Patel KK, Mejia Munne JC, Gunness VRN, Hersey D, Alshafai N, Sciubba D, Nasser R, Gimbel D, Cheng J, Nouri A. Subacute combined degeneration of the
spinal cord following nitrous oxide anesthesia: A systematic review of cases. Clin Neurol Neurosurg. 2018 Oct;173:163-168. doi: 10.1016/j.clineuro.2018.08.016.
Epub 2018 Aug 9. Erratum in: Clin Neurol Neurosurg. 2019 Feb;177:123-124. Abstract corrected. PubMed PMID: 30144777.
Jolobe OMP. Other aspects of nitrous oxide-related neuromyelopathy. Am J Emerg Med. 2019 Feb;37(2):350-351. doi: 10.1016/j.ajem.2018.05.076. Epub 2018 May 30. PubMed PMID: 29866413.
Egan W, Steinberg E, Rose J. Vitamin B(12) deficiency-induced neuropathy secondary to prolonged recreational use of nitrous oxide. Am J Emerg Med. 2018
Sep;36(9):1717.e1-1717.e2. doi: 10.1016/j.ajem.2018.05.029. Epub 2018 May 24. PubMed PMID: 29859645.
Anderson D, Beecher G, van Dijk R, Hussain M, Siddiqi Z, Ba F. Subacute Combined Degeneration from Nitrous Oxide Abuse in a Patient with Pernicious
Anemia. Can J Neurol Sci. 2018 May;45(3):334-335. doi: 10.1017/cjn.2018.15. PubMed PMID: 29756593.
Antonucci MU. Subacute Combined Degeneration from Recreational Nitrous Oxide Inhalation. J Emerg Med. 2018 May;54(5):e105-e107. doi: 10.1016/j.jemermed.2018.01.045. Epub 2018 Mar 27. PubMed PMID: 29602528.
Keddie S, Adams A, Kelso ARC, Turner B, Schmierer K, Gnanapavan S, Malaspina A, Giovannoni G, Basnett I, Noyce AJ. No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation. J Neurol. 2018 May;265(5):1089-1095. doi: 10.1007/s00415-018-8801-3. Epub 2018 Mar 3. PubMed
PMID: 29502317; PubMed Central PMCID: PMC5937900.
Johnson K, Mikhail P, Kim MG, Bosco A, Huynh W. Recreational nitrous oxide-associated neurotoxicity. J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):897-898. doi: 10.1136/jnnp-2017-317768. Epub 2018 Jan 24. PubMed PMID: 29367261.
Al-Sadawi M, Claris H, Archie C, Jayarangaiah A, Oluya M, McFarlane SI. Inhaled Nitrous Oxide 'Whip-Its!' Causing Subacute Combined Degeneration of
Spinal Cord. Am J Med Case Rep. 2018;6(12):237-240. doi: 10.12691/ajmcr-6-12-3. Epub 2018 Dec 26. PubMed PMID: 31058215; PubMed Central PMCID: PMC6499494.
Friedlander G, Davies T. The Last Laugh - Reversible myeloneuropathy induced by chronic nitrous oxide use. Acute Med. 2018;17(4):232-235. PubMed PMID:
Yuan JL, Wang SK, Jiang T, Hu WL. Nitrous oxide induced subacute combined degeneration with longitudinally extensive myelopathy with inverted V-sign on
spinal MRI: a case report and literature review. BMC Neurol. 2017 Dec 28;17(1):222. doi: 10.1186/s12883-017-0990-3. PubMed PMID: 29282001; PubMed
Central PMCID: PMC5745895.
Conjaerts SHP, Bruijnes JE, Beerhorst K, Beekman R. [Nitrous oxide-induced polyneuropathy]. Ned Tijdschr Geneeskd. 2017;161:D2044. Dutch. PubMed PMID:
Kaski D, Kumar P, Murphy E, Warner TT. Iatrogenic B12-deficient peripheral neuropathy following nitrous oxide administration for functional tonic leg spasm:
A case report. Clin Neurol Neurosurg. 2017 Sep;160:108-110. doi:10.1016/j.clineuro.2017.07.006. Epub 2017 Jul 6. PubMed PMID: 28709008.
Stockton L, Simonsen C, Seago S. Nitrous oxide-induced vitamin B12 deficiency. Proc (Bayl Univ Med Cent). 2017 Apr;30(2):171-172. PubMed PMID: 28405070; PubMed Central PMCID: PMC5349816.
Buizert A, Sharma R, Koppen H. When the Laughing Stops: Subacute Combined Spinal Cord Degeneration Caused by Laughing Gas Use. J Addict Med. 2017
May/Jun;11(3):235-236. doi: 10.1097/ADM.0000000000000295. PubMed PMID: 28166085.
40: Chen HJ, Huang CS. Nitrous Oxide-induced Subacute Combined Degeneration Presenting with Dystonia and Pseudoathetosis: A Case Report. Acta Neurol Taiwan. 2016 Jun 15;25(2):50-55. PubMed PMID: 27854092.
Mancke F, Kaklauskaitė G, Kollmer J, Weiler M. Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report. Subst Abuse Rehabil. 2016 Sep 29;7:155-159. eCollection 2016.PubMed PMID: 27729826; PubMed Central PMCID: PMC5047713.
Massey TH, Pickersgill TT, J Peall K. Nitrous oxide misuse and vitamin B12 deficiency. BMJ Case Rep. 2016 May 31;2016. pii: bcr2016215728. doi:10.1136/bcr-2016-215728. PubMed PMID: 27247211; PubMed Central PMCID: PMC4904416.
Duque MA, Kresak JL, Falchook A, Harris NS. Nitrous Oxide Abuse and Vitamin B12 Action in a 20-Year-Old Woman: A Case Report. Lab Med. 2015 Fall;46(4):312-5. doi: 10.1309/LM0L9HAVXCHF1UQM. PubMed PMID: 26489675.
Pugliese RS, Slagle EJ, Oettinger GR, Neuburger KJ, Ambrose TM. Subacute combined degeneration of the spinal cord in a patient abusing nitrous oxide and
self-medicating with cyanocobalamin. Am J Health Syst Pharm. 2015 Jun 1;72(11):952-7. doi: 10.2146/ajhp140583. PubMed PMID: 25987690.
Morris N, Lynch K, Greenberg SA. Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiency. Muscle
Nerve. 2015 Apr;51(4):614-6. doi: 10.1002/mus.24482. Epub 2015 Feb 24. PubMedPMID: 25297001.
Garakani A, Welch AK, Jaffe RJ, Protin CA, McDowell DM. Psychosis and low cyanocobalamin in a patient abusing nitrous oxide and cannabis. Psychosomatics.
2014 Nov-Dec;55(6):715-9. doi: 10.1016/j.psym.2013.11.001. Epub 2013 Nov 5.PubMed PMID: 24367897.
Safari A, Emadi F, Jamali E, Borhani-Haghighi A. Clinical and MRI manifestations of nitrous oxide induced vitamin B12 deficiency: A case report. Iran J Neurol. 2013;12(3):111-3. PubMed PMID: 24250916; PubMed Central PMCID: PMC3829298.
Chiang TT, Hung CT, Wang WM, Lee JT, Yang FC. Recreational nitrous oxide abuse-induced vitamin B12 deficiency in a patient presenting with
hyperpigmentation of the skin. Case Rep Dermatol. 2013 Jun 29;5(2):186-91. doi: 10.1159/000353623. Print 2013 May. PubMed PMID: 23898268; PubMed Central PMCID: PMC3724136.
Chaugny C, Simon J, Collin-Masson H, De Beauch?ne M, Cabral D, Fagniez O, Veyssier-Belot C. [Vitamin B12 deficiency due to nitrous oxide use: unrecognized
cause of combined spinal cord degeneration]. Rev Med Interne. 2014 May;35(5):328-32. doi: 10.1016/j.revmed.2013.04.018. Epub 2013 Jun 14. French. PubMed PMID: 23773901.
Cheng HM, Park JH, Hernstadt D. Subacute combined degeneration of the spinal cord following recreational nitrous oxide use. BMJ Case Rep. 2013 Mar 8;2013.
pii: bcr2012008509. doi: 10.1136/bcr-2012-008509. PubMed PMID: 23476009; PubMed Central PMCID: PMC3618752.
Ghobrial GM, Dalyai R, Flanders AE, Harrop J. Nitrous oxide myelopathy posing as spinal cord injury. J Neurosurg Spine. 2012 May;16(5):489-91. doi:10.3171/2012.2.SPINE11532. Epub 2012 Mar 2. PubMed PMID: 22385084.
Probasco JC, Felling RJ, Carson JT, Dorsey ER, Niessen TM. Teaching NeuroImages: myelopathy due to B₁₂ deficiency in long-term colchicine treatment
and nitrous oxide misuse. Neurology. 2011 Aug 30;77(9):e51. doi:10.1212/WNL.0b013e31822c910f. PubMed PMID: 21876193.
Lin RJ, Chen HF, Chang YC, Su JJ. Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurol Taiwan. 2011 Jun;20(2):129-37. Review. PubMed PMID: 21739392.
Hathout L, El-Saden S. Nitrous oxide-induced B12 deficiency myelopathy: Perspectives on the clinical biochemistry of vitamin B12. J Neurol Sci. 2011 Feb
15;301(1-2):1-8. doi: 10.1016/j.jns.2010.10.033. Epub 2010 Nov 26. Review. PubMed PMID: 21112598.
Alt RS, Morrissey RP, Gang MA, Hoffman RS, Schaumburg HH. Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse. J Emerg Med. 2011
Oct;41(4):378-80. doi: 10.1016/j.jemermed.2010.04.020. Epub 2010 Jun 7. PubMed PMID: 20605391.
Richardson PG. Peripheral neuropathy following nitrous oxide abuse. Emerg Med Australas. 2010 Feb;22(1):88-90. doi: 10.1111/j.1742-6723.2009.01262.x. PubMedPMID: 20152009.
Wijesekera NT, Davagnanam I, Miszkiel K. Subacute combined cord degeneration: a rare complication of nitrous oxide misuse. A case report. Neuroradiol J. 2009
May 15;22(2):194-7. Epub 2009 May 15. PubMed PMID: 24207040.
Renard D, Dutray A, Remy A, Castelnovo G, Labauge P. Subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia. Neurol Sci.
2009 Feb;30(1):75-6. doi: 10.1007/s10072-009-0013-2. Epub 2009 Jan 24. PubMed PMID: 19169627.
Jameson M, Roberts S, Anderson NE, Thompson P. Nitrous oxide-induced vitamin B(12) deficiency. J Clin Neurosci. 1999 Mar;6(2):164-6. PubMed PMID: 18639144.
Sethi NK, Mullin P, Torgovnick J, Capasso G. Nitrous oxide "whippit" abuse presenting with cobalamin responsive psychosis. J Med Toxicol. 2006 Jun;2(2):71-4. Review. PubMed PMID: 18072118; PubMed Central PMCID: PMC3550053.
Krajewski W, Kucharska M, Pilacik B, Fobker M, Stetkiewicz J, Nofer JR, Wronska-Nofer T. Impaired vitamin B12 metabolic status in healthcare workers
occupationally exposed to nitrous oxide. Br J Anaesth. 2007 Dec;99(6):812-8. Epub 2007 Oct 20. PubMed PMID: 17951609.
Wu MS, Hsu YD, Lin JC, Chen SC, Lee JT. Spinal myoclonus in subacute combined degeneration caused by nitrous oxide intoxication. Acta Neurol Taiwan. 2007
Jun;16(2):102-5. PubMed PMID: 17685135.
Singer MA, Lazaridis C, Nations SP, Wolfe GI. Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review. Muscle Nerve. 2008 Jan;37(1):125-9. PubMed PMID: 17623854.
Cohen Aubart F, Sedel F, Vicart S, Lyon-Caen O, Fontaine B. [Nitric-oxide triggered neurological disorders in subjects with vitamin B12 deficiency]. Rev Neurol (Paris). 2007 Mar;163(3):362-4. French. PubMed PMID: 17404524.
Ahn SC, Brown AW. Cobalamin deficiency and subacute combined degeneration after nitrous oxide anesthesia: a case report. Arch Phys Med Rehabil. 2005 Jan;86(1):150-3. PubMed PMID: 15641006.
Miller MA, Martinez V, McCarthy R, Patel MM. Nitrous oxide "whippit" abuse presenting as clinical B12 deficiency and ataxia. Am J Emerg Med. 2004 Mar;22(2):124. PubMed PMID: 15011232.
Waclawik AJ, Luzzio CC, Juhasz-Pocsine K, Hamilton V. Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels.
WMJ. 2003;102(4):43-5. Erratum in: WMJ. 2003;102(6):5. PubMed PMID: 12967021.
Ilniczky S, Jelencsik I, Ken?z J, Szirmai I. MR findings in subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia--two cases.
Eur J Neurol. 2002 Jan;9(1):101-4. PubMed PMID: 11784385.
Barbosa L, Leal I, Tim?teo AT, Matias T. [Acute megaloblastic anemia caused by inhalation of nitrous oxide in a patient with multiple autoimmune pathology]. Acta Med Port. 2000 Sep-Dec;13(5-6):309-12. Portuguese. PubMed PMID: 11234497.
Deleu D, Hanssens Y, Louon A. Nitrous oxide-induced cobalamin deficiency. Arch Neurol. 2001 Jan;58(1):134-5. PubMed PMID: 11176951.
McNeely JK, Buczulinski B, Rosner DR. Severe neurological impairment in an infant after nitrous oxide anesthesia. Anesthesiology. 2000 Dec;93(6):1549-50.
PubMed PMID: 11149458.
Felmet K, Robins B, Tilford D, Hayflick SJ. Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide. J Pediatr. 2000 Sep;137(3):427-8. PubMed PMID: 10969273.
Mari? RM, Le Biez E, Busson P, Schaeffer S, Boiteau L, Dupuy B, Viader F. Nitrous oxide anesthesia-associated myelopathy. Arch Neurol. 2000 Mar;57(3):380-2. PubMed PMID: 10714665.
G?the CJ, Petersson G. [Nitrous oxide and cobalamin deficiency]. Lakartidningen. 1999 Dec 15;96(50):5609. Swedish. PubMed PMID: 10643221.
Lindstedt G. [Nitrous oxide can cause cobalamin deficiency. Vitamin B12 is a simple and cheap remedy]. Lakartidningen. 1999 Nov 3;96(44):4801-5. Review.
Swedish. PubMed PMID: 10584542.
Alarcia R, Ara JR, Serrano M, Garc?a M, Latorre AM, Capablo JL. [Severe polyneuropathy after using nitrous oxide as an anesthetic. A preventable disease?]. Rev Neurol. 1999 Jul 1-15;29(1):36-8. Spanish. PubMed PMID: 10528308.
Sesso RM, Iunes Y, Melo AC. Myeloneuropathy following nitrous oxide anesthaesia in a patient with macrocytic anaemia. Neuroradiology. 1999 Aug;41(8):588-90. PubMed PMID: 10447571.
Mayall M. Vitamin B12 deficiency and nitrous oxide. Lancet. 1999 May 1;353(9163):1529. PubMed PMID: 10232347.
Pema PJ, Horak HA, Wyatt RH. Myelopathy caused by nitrous oxide toxicity. AJNR Am J Neuroradiol. 1998 May;19(5):894-6. PubMed PMID: 9613506.
Beltramello A, Puppini G, Cerini R, El-Dalati G, Manfredi M, Roncolato G, Idone D, De Togni L, Turazzini M. Subacute combined degeneration of the spinal
cord after nitrous oxide anaesthesia: role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):563-4. PubMed PMID: 9576560; PubMed
Central PMCID: PMC2170040.
Horne DW, Holloway RS. Compartmentation of folate metabolism in rat pancreas: nitrous oxide inactivation of methionine synthase leads to accumulation of 5-methyltetrahydrofolate in cytosol. J Nutr. 1997 Sep;127(9):1772-5. PubMed PMID: 9278558.
Tak?cs J. [N2O-induced acute funicular myelosis in latent vitamin B 12 deficiency]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1996 Oct;31(8):525-8. German. PubMed PMID: 9019188.
Nestor PJ, Stark RJ. Vitamin B12 myeloneuropathy precipitated by nitrous oxide anaesthesia. Med J Aust. 1996 Aug 5;165(3):174. PubMed PMID: 8709889.
R?sener M, Dichgans J. Severe combined degeneration of the spinal cord after nitrous oxide anaesthesia in a vegetarian. J Neurol Neurosurg Psychiatry. 1996
Mar;60(3):354. PubMed PMID: 8609528; PubMed Central PMCID: PMC1073874.
Hadzic A, Glab K, Sanborn KV, Thys DM. Severe neurologic deficit after nitrous oxide anesthesia. Anesthesiology. 1995 Oct;83(4):863-6. Review. PubMed PMID: 7574068.
King M, Coulter C, Boyle RS, Whitby RM. Neurotoxicity from overuse of nitrous oxide. Med J Aust. 1995 Jul 3;163(1):50-1. PubMed PMID: 7609693.
Young PB, Kennedy S, Molloy AM, Scott JM, Weir DG, Kennedy DG. Effect of N2O treatment/vitamin B12 deficiency in pigs on tissue concentrations of odd-numbered, branched-chain fatty acids. Int J Vitam Nutr Res.1995;65(4):255-60. PubMed PMID: 8789622.
Louis-Ferdinand RT. Myelotoxic, neurotoxic and reproductive adverse effects of nitrous oxide. Adverse Drug React Toxicol Rev. 1994 Winter;13(4):193-206.Review. PubMed PMID: 7734639.
Flippo TS, Holder WD Jr. Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. Arch Surg. 1993 Dec;128(12):1391-5. Review. PubMed PMID: 8250714.
Carmel R, Rabinowitz AP, Mazumder A. Metabolic evidence of cobalamin deficiency in bone marrow cells harvested for transplantation from donors given nitrous oxide. Eur J Haematol. 1993 Apr;50(4):228-33. PubMed PMID: 8500605.
Koblin DD, Tomerson BW, Waldman FM, Lampe GH, Wauk LZ, Eger EI 2nd. Effect of nitrous oxide on folate and vitamin B12 metabolism in patients. Anesth Analg. 1990 Dec;71(6):610-7. PubMed PMID: 2240633.
Koblin DD, Tomerson BW, Waldman FM. Disruption of folate and vitamin B12 metabolism in aged rats following exposure to nitrous oxide. Anesthesiology. 1990 Sep;73(3):506-12. PubMed PMID: 2393136.
van Achterbergh SM, Vorster BJ, Heyns AD. The effect of sepsis and short-term exposure to nitrous oxide on the bone marrow and the metabolism of vitamin B12 and folate. S Afr Med J. 1990 Sep 1;78(5):260-3. PubMed PMID: 2392722.
van der Westhuyzen J, Davis RE, Icke GC, Metz J. Tissue folates in fruit bats (Rousettus aegyptiacus) with nitrous oxide-induced vitamin B12 deficiency and neurological impairment. Br J Nutr. 1987 Nov;58(3):485-91. PubMed PMID:3120768.
Van de List C, Combs M, Schilling RF. Nitrous oxide and vitamin B12 deficiency interact adversely on rat growth. J Lab Clin Med. 1986 Oct;108(4):346-8. PubMed PMID: 3760674.
Koblin DD, Biebuyck JF. Is nitrous oxide a dangerous anesthetic for vitamin B12-deficient subjects? JAMA. 1986 Aug 8;256(6):716. PubMed PMID: 3723770.
Schilling RF. Is nitrous oxide a dangerous anesthetic for vitamin B12-deficient subjects? JAMA. 1986 Mar 28;255(12):1605-6. PubMed PMID: 3951096.
McLoughlin JL, Cantrill RC. Nitrous oxide induced vitamin B12 deficiency: measurement of methylation reactions in the fruit bat (Rousettus aegyptiacus).
Int J Biochem. 1986;18(2):199-202. PubMed PMID: 3949064.
Wilson SD, Horne DW. Effect of nitrous oxide inactivation of vitamin B12 on the levels of folate coenzymes in rat bone marrow, kidney, brain, and liver. Arch Biochem Biophys. 1986 Jan;244(1):248-53. PubMed PMID: 3947060.
van Tonder SV, Ruck A, van der Westhuyzen J, Fernandes-Costa F, Metz J. Dissociation of methionine synthetase (EC 220.127.116.11) activity and impairment of
DNA synthesis in fruit bats (Rousettus aegyptiacus) with nitrous oxide-induced vitamin B12 deficiency. Br J Nutr. 1986 Jan;55(1):187-92. PubMed PMID: 3663573.
van der Westhuyzen J, van Tonder SV, Gibson JE, Kilroe-Smith TA, Metz J.Plasma amino acids and tissue methionine levels in fruit bats (Rousettus aegyptiacus) with nitrous oxide-induced vitamin B12 deficiency. Br J Nutr. 1985 May;53(3):657-62. PubMed PMID: 4063293.
O'Leary PW, Combs MJ, Schilling RF. Synergistic deleterious effects of nitrous oxide exposure and vitamin B12 deficiency. J Lab Clin Med. 1985 Apr;105(4):428-31. PubMed PMID: 3981056.
van der Westhuyzen J, Metz J. Betaine delays the onset of neurological impairment in nitrous oxide-induced vitamin B-12 deficiency in fruit bats. J Nutr. 1984 Jun;114(6):1106-11. PubMed PMID: 6726473.
van der Westhuyzen J, Fernandes-Costa F, Metz J. Cobalamin inactivation by nitrous oxide produces severe neurological impairment in fruit bats : protection by methionine and aggravation by folates. Life Sci. 1982 Nov 1;31(18):2001-10. PubMed PMID: 7176808.
Lumb M, Perry J, Deacon R, Chanarin I. Urinary folate loss following inactivation of vitamin B12 by nitrous oxide in rats. Br J Haematol. 1982 Jun;51(2):235-42. PubMed PMID: 7082582.
Kondo H, Osborne ML, Kolhouse JF, Binder MJ, Podell ER, Utley CS, Abrams RS, Allen RH. Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats. J Clin Invest. 1981 May;67(5):1270-83. PubMed PMID: 6112240; PubMed Central PMCID: PMC370693.
Steinberg SE, Campbell C, Hillman RS. The effect of nitrous oxide-induced vitamin B12 deficiency on in vivo folate metabolism. Biochem Biophys Res Commun.
1981 Feb 27;98(4):983-9. PubMed PMID: 6164371.
McKenna B, Weir DG, Scott JM. The induction of functional vitamin B-12 deficiency in rats by exposure to nitrous oxide. Biochim Biophys Acta. 1980 Mar 20;628(3):314-21. PubMed PMID: 7370297.
Lumb M, Deacon R, Perry J, Chanarin I, Minty B, Halsey MJ, Nunn JF. The effect of nitrous oxide inactivation of vitamin B12 on rat hepatic folate.Implications for the methylfolate-trap hypothesis. Biochem J. 1980 Mar 15;186(3):933-6. PubMed PMID: 7396845; PubMed Central PMCID: PMC1161731.
Adornato BT. Nitrous oxide and vitamin B12. Lancet. 1978 Dec 16;2(8103):1318. PubMed PMID: 82831.
Deacon R, Lumb M, Perry J, Chanarin I, Minty B, Halsey MJ, Nunn JF. Selective inactivation of vitamin B12 in rats by nitrous oxide. Lancet. 1978 Nov
11;2(8098):1023-4. PubMed PMID: 82036.
Amess JA, Burman JF, Rees GM, Nancekievill DG, Mollin DL. Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet. 1978 Aug12;2(8085):339-42. PubMed PMID: 79709.
Shetty etal. Management of Ocular Neuropathic pain with vitamin B12 supplements: A case report. Cornea 2015, 1324-5 PMID 26266431
Ulak etal, 2016 Vitamin status among breastfed infants in Bhaktapur, Nepal. PMC 4808878
Wickramasinghe SN1, Ratnayaka ID. Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocytosis.
England JM, Linnell JC. Problems with the serum vitamin B12
assay. Lancet.1980 Nov 15;2(8203):1072-4. PubMed PMID: 6107691.
J Clin Pathol. 1996 Sep;49(9):755-8. https://www.ncbi.nlm.nih.gov/pubmed/9038761
James SJ, Melnyk S, Jernigan S et al. Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. J Autism Dev Disord 2008;38:1966-75.
James SJ, Melnyk S, Pogribna M et al. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002;132:2361S-66S.
Yi P, Melnyk S, Pogribna M et al. Increase in plasma homocysteine associated with parallel increase in plasma S-andenosylhomocysteine and lymphocyte DNA hypomethylation. JBC 2000;275:29318- 23.
Armed etal, 2019 Vitamin B12 deficiency and hyperhomocysteinaemia
in outpatients with stroke of transient ischaemic stroke..
Andres etal, 2013 The pathophysiology of elevated vitamin B12 in clinical practice https://academic.oup.com/jmed/article/106/6/505/1538806
Chiche etal, 2008 Implications cliiques de la decourverte d'une hpervitaminemie B12 en medecien interne. Rev Med Interne 29, 187-194
Arendt and Nexo 2012 Cobalamin related parameters and disease patterns in patients with increased serum colabamin levels. PLoS ONE 9, e45979
Deneuville etal, Concentration plasmatique elevee de la vitamine B12.... REv Med Interne 2009 30, S73
Corbetta etal, 2015 Pardoxical increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa. PMID 25446249 https://practicalgastro.com/2019/07/31/revisiting-vitamin-b12-deficiency-a-clinicians-guide-for-the-21st-century/
Copyright ? 2018
vitaminb12deficiency.info. All Rights Reserved.
The statements on this site compose a compendium of generally recognized signs of vitamin B12 deficiency, and problems that can then ensue They also are formulated from a summary of relevant scientific publications. In addition they may contain some forward looking statements of a general nature.
Reproduction in whole or in part in any form or medium without express written permission is prohibited